Strava Healthcare is a leading manufacturer, supplier and exporter of citicoline 500 mg tablets in India mainly for pharmaceutical brands, neurology distributors, and export markets. Citicoline CDP-choline is a compound that the body produces naturally and uses to build phosphatidylcholine in neuronal membranes. The clinical evidence holds up best in acute ischaemic stroke, traumatic brain injury, and age-related cognitive decline. It is not a nootropic supplement. The pharmacology and the trial data put it in a different category entirely. Citicoline is emerging demand in LATAM market like Costa Rica, Ecuador, Guatemala, and Honduras as well as in Myanmar and Cambodia.
Manufacturing is GMP-certified with batch assay and impurity profiling. Full documentation is available for regulatory submissions.
Clinical Applications
- Adjunctive treatment in ischaemic stroke and cerebrovascular disorders
- Traumatic brain injury and post-surgical neurological recovery
- Age-related cognitive decline and mild cognitive impairment
- Glaucoma — some evidence for retinal ganglion cell neuroprotection
- Memory and attention support in geriatric patients
For B2B and Pharma Partners
- Contract manufacturing with custom branding and packaging
- Private label: 500 mg tablets ready for market
- Bulk supply for neurological specialty distributors and export
Product Specifications
| Parameter | Details |
|---|---|
Active Ingredient | Citicoline sodium (CDP-choline) |
Strength | 500 mg |
Dosage Form | Film-coated tablet |
Packaging Sizes | Blisters of 10s, 30s; bottles of 60s, 100s |
Storage | Below 30°C, protected from moisture |
Shelf Life | 36 months |
Manufacturer | Strava Healthcare Private Limited |
Frequently Asked Questions
500 mg twice daily is the most studied dose for stroke rehabilitation and cognitive indications. Certain protocols go to 1,000 to 2,000 mg per day. The Duration mainly depends on the indication acute stroke studies have run 6-week courses; cognitive support tends to be longer. Prescriber guidance applies in all cases.
No. Choline supplements raise systemic choline. Citicoline supplies both choline and cytidine and cytidine and it converts to uridine centrally, which is pharmacologically distinct. The evidence base reflects that difference. Citicoline has controlled trial data behind it. Most basic choline supplements do not.
Yes. We supply to neurology distributors and specialty pharmaceutical buyers domestically and for export. Dossier support and COPP are available on request.
